Ditch the VC: Alternative Funding Options for Biotech Startups
Getting money for a biotech startup can be a daunting task. Venture capital is not…
Getting money for a biotech startup can be a daunting task. Venture capital is not…
Sofinnova Partners’ Chairman and Managing Partner, Antoine Papiernik, describes his company’s ‘Wall of Fame’ showcasing…
Antoine Papiernik, Chairman and Managing Partner at Sofinnova Partners, looks back at where he was…
There is usually a big disparity between investors and entrepreneurs regarding the valuation of an…
Covid-19 has been dominating the news for weeks on end, but what impact is the…
For a few decades, the worlds of biotech and digital technology have been on separate…
Traditionally European biotechs have looked to the US for additional investment, but changes in the…
Early-stage investments in the healthcare sector are often dominated by public money, which is directly…
Sofinnova Partners, Europe’s largest VC focused on life sciences, has raised €333M to fund early-stage…
VC firm Wellington Partners has raised its fifth fund dedicated to investing in life science…
Update (25/06/2019): The Luxembourg-based investor Vesalius Biocapital III has completed the final closing of a…
The biotech sector is rapidly gaining momentum in Spain. At Labiotech Refresh in Barcelona, Raúl…